Gideon Capital Advisors’s Celgene Corp CELG Stock Holding History

Gideon Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,161	Closed	-$393K	–	499
2019 Q1	$393K	Buy	+4,161	New	+$364K	0.14%	224
2018 Q4	–	Sell	-5,071	Closed	-$454K	–	560
2018 Q3	$454K	Buy	+5,071	New	+$448K	0.21%	163
2018 Q1	–	Sell	-4,242	Closed	-$443K	–	521
2017 Q4	$443K	Buy	4,242 +1,294	+44%	+$146K	0.39%	66
2017 Q3	$430K	Sell	2,948 -611	-17%	-$83.2K	0.42%	64
2017 Q2	$462K	Buy	3,559 +937	+36%	+$115K	0.51%	53
2017 Q1	$326K	Sell	2,622 -3,155	-55%	-$378K	0.19%	223
2016 Q4	$669K	Buy	+5,777	New	+$643K	0.43%	39
2015 Q2	–	Sell	-3,648	Closed	-$421K	–	356
2015 Q1	$421K	Buy	+3,648	New	+$436K	0.17%	169
2014 Q2	–	Sell	-8,478	Closed	-$592K	–	352
2014 Q1	$592K	Buy	+8,478	New	+$671K	0.33%	102

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Gideon Capital Advisors's CELG Position: Q2 2019 in Review

Gideon Capital Advisors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 4,161 shares — an estimated $393K sold.

Gideon Capital Advisors first reported a position in CELG in Q1 2014 and held it in 9 quarters. The position peaked at $669K in Q4 2016. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Gideon Capital Advisors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Gideon Capital Advisors sold 4,161 Celgene Corp shares in Q2 2019, an estimated $393K.
Gideon Capital Advisors first reported a position in Celgene Corp in Q1 2014 and held it in 9 quarters.
Gideon Capital Advisors's Celgene Corp position peaked at $669K in Q4 2016.
1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Gideon Capital Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.